The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2020

Contralateral prophylactic mastectomy for unilateral breast cancer in
women at average risk: Systematic review of patient reported outcomes
Amilee Srethbhakdi
Meagan E. Brennan
The University of Notre Dame Australia, meagan.brennan@nd.edu.au

Geaty Hamid
Kathy Flitcroft

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This article was originally published as:
Srethbhakdi, A., Brennan, M. E., Hamid, G., & Flitcroft, K. (2020). Contralateral prophylactic mastectomy for unilateral breast cancer in
women at average risk: Systematic review of patient reported outcomes. Psycho-Oncology, Early View Online First.
Original article available here:
10.1002/pon.5379

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/1150. For more
information, please contact researchonline@nd.edu.au.

Copyright ©2020 John Wiley & Sons Ltd. All rights reserved.
This is the peer reviewed version of the following article:
Srethbhakdi, A., Brennan, M.E., Hamid, G., and Flitcroft, K. (2020). Contralateral prophylactic
mastectomy for unilateral breast cancer in women at average risk: Systematic review of
patient reported outcomes. Psycho-Oncology, Early View Online First, doi: 10.1002/pon.5379
This article has been published in final form at: https://doi.org/10.1002/pon.5379

This article may be used for non-commercial purposes in accordance with Wiley Terms and
Conditions for self-archiving.

A Systematic Review of Psychosocial Outcomes following Contralateral Prophylactic
Mastectomy in Average Risk Women
Running title
Contralateral prophylactic mastectomy patient-reported outcomes
Authors
Amilee Srethbhakdi
School of Medicine, Faculty of Medicine and Health, University of Sydney
asre7187@uni.sydney.edu.au
Meagan E. Brennan
School of Medicine, Faculty of Medicine and Health, University of Sydney
School of Medicine, Sydney, University of Notre Dame Australia
Meagan.brennan@sydney.edu.au
Geaty Hamid
Westmead Breast Cancer Institute, Westmead Hospital, Westmead, Australia
Geaty.hamid@health.nsw.gov.au
Kathy Flitcroft
School of Medicine, Faculty of Medicine and Health, University of Sydney
Kathy.flitcroft@melanoma.org.au

1

Abstract
Objective
The rate of contralateral prophylactic mastectomy (CPM) in women with early, unilateral
cancer is relatively high and is increasing world-wide1,2. Women choose this option for many
reasons other than reducing their risk of future cancer, including symmetry, breast
reconstruction-related reasons and attempting to manage fear of recurrence. This
systematic review evaluated patient-reported quality of life outcomes following CPM.
Methods
A literature search of MEDLINE, PubMed and PsycINFO was performed to February 2019.
Abstracts and full-text articles were assessed for eligibility according to pre-determined
criteria. Data were extracted into evidence tables for analysis.
Results
19 articles met eligibility criteria for inclusion in analysis. These included patient-reported
data from 6088 women undergoing CPM. They reported high levels of satisfaction with the
decision for surgery, low levels of decisional regret and high satisfaction with cosmesis and
reconstruction. Breast-specific and general quality of life was high overall but was even
better in women choosing breast reconstruction after surgery. Fear of cancer recurrence
was high after CPM. Depression, distress and a negative impact on body image were
evident; however, levels were high in both CPM and non-CPM groups.
Conclusions
This study provides information that can be used by surgeons and psychologists when
counselling women about the potential benefits and harms of CPM. This process must
include discussion about the trade-offs such as body image issues and ongoing fear of
recurrence in addition to the positive aspect of cancer risk reduction. Women are unlikely to
regret their decision for CPM.

Keywords
cancer, breast neoplasms, patient outcome assessment, prophylactic mastectomy
PROSPERO ID: 148419
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Background
For women at average risk of breast cancer with early-stage, unilateral cancer, the risk of a
future contralateral breast cancer is low, around 0.13% per year1,2. No survival benefit has
been found from contralateral prophylactic mastectomy (CPM) in women without a high
hereditary risk of breast cancer3,4. Despite this low risk and a lack of survival benefit, the rate
of CPM in women with unilateral cancer is relatively high and is increasing world-wide1,2. In
women with a first diagnosis of unilateral breast cancer undergoing mastectomy, the rate of
CPM has increased significantly from 4–6% to 13–24% between 2002 and 20121,5
Women often overestimate their risk of contralateral cancer and this may contribute to the
high CPM rates6,7. However, when reasons for CPM have been studied, women have
reported that risk is not always the most important factor in their decision-making. Rather,
fear of cancer recurrence, the desire for symmetry and reasons related to breast
reconstruction (such as limitations on having a second autologous reconstruction in the
future) are important factors8. A previous systematic review evaluating decision-making
found that women who choose CPM are generally satisfied with the decision, although there
is a paucity of research examining other patient-reported outcomes.8
Current clinical guidelines recommend against the use of CPM except in women at high
genetic risk of breast cancer9. Clinicians have expressed alarm about the increasing trend
towards CPM2,10 and this has driven research into decision-making and outcomes8. The
current study aims to perform a systematic review to evaluate patient-reported outcomes
following CPM on general and breast-specific quality of life (QoL) and other outcomes
including satisfaction, body image, sexuality, decisional regret, and fear of cancer
recurrence. It also aims to provide information to enhance the pre-operative discussion that
women considering CPM have with their clinicians.

Methods
A literature search was performed to identify studies that included patient-reported outcomes
in women with unilateral breast malignancy undergoing therapeutic mastectomy with CPM.
The eligibility criteria and search strategy are shown in online supplemental material
(Appendices 1 and 2).
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Abstracts and full-text papers were screened for eligibility by one author (AS) and checked
by another (MB). Data were extracted from eligible full-text papers and transferred to
evidence tables by one author (AS) and checked for accuracy by another (MB or KS). Cases
of uncertain eligibility or discrepant data were solved by consensus. The following data were
extracted: (a) study characteristics: year of publication, country where study was conducted,
prospective or retrospective methodology, number and age of participants, description of
participants/population and comparison group, outcomes assessed, method of assessment
of outcomes (e.g. questionnaire, focus group, interview), outcome measure type
(scales/subscales used), description and validation of outcome tools; (b) study results:
timing of outcome measures relative to surgery, results of outcome measures and study
conclusion; (c) Breast-Q data: as this was the most frequently used measurement tool,
additional detail about subscales and results was collected for studies using Breast-Q. All
data were examined for common themes and presented in summary tables.
Each study was allocated a quality score by two authors using an adaptation of the QualSyst
score which was described by Kmet et al11 and adapted for use in a previous systematic
review of patient-reported outcomes in breast cancer by Flitcroft et al12,13. Studies were
scored on 12 items on a 0–2 scale for a total possible score of 24 and a mean score was
calculated.

Results
The outcomes from the search strategy are shown in the PRISMA flowchart in Figure 1. The
search identified 1612 abstracts (earliest date searched to February 2019). 81 abstracts met
eligibility criteria. 81 full-text articles were reviewed, 63 were subsequently deemed
ineligible, and 1 article was added following review of reference lists of eligible studies. 19
studies were eligible for inclusion in the analysis.7,14-32
Study characteristics
The 19 studies included patient-reported outcomes from 6088 women. The study
characteristics are shown in Table 1. The studies were published between 1999 and 2018.
17 studies were performed in the United States and 2 across both the US and Canada.
There were 2 prospective and 17 retrospective studies. Participants provided information by
questionnaire (15 studies), interview (2 studies) or a combination of both (2 studies).
Study quality
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All studies were rated for quality by two authors against a standardised checklist11-13. There
was good concordance between raters, with a mean difference in scores of 1.6 (range 0–3)
on the 24-point scale. There were differences in quality scores between included studies,
with the lowest score 14 and the highest score 22 out of 24. Studies were most likely to be
rated lower if they did not adequately describe the study sample, sampling strategy or
outcome measures, or did not connect the study to the wider body of knowledge. The
higher-quality studies tended to be larger (with over 100 participants), to have well-described
methodology and to use validated measurement tools. The more recent studies (2013
onwards) also tended to have higher quality scores. The mean study score was 19.1
(median 19.5). Of the 19 studies, 8 had a quality score over 20, indicating a high quality.
Patient-reported outcomes (PROs) evaluated in studies
The studies reported a range of PROs, as shown in Tables 1–3 and online supplemental
material (Appendix 3). These were grouped into 10 main domains: breast-related QoL
(reported in 5 studies18,24-27, satisfaction with decision for CPM (12 studies)7,14-16,20-23,28-31,
satisfaction with reconstruction and cosmesis (4 studies)15,16,30,31, overall QoL (3
studies)21,22,32, fear of cancer recurrence (5 studies)16,21,22,29,30, body image (4
studies)15,21,22,30, sexuality (4 studies)16,19,22,30, distress (3 studies)21,22,32, combined body
image/sexuality (2 studies)14,20 and other outcomes (5 studies)21,22,29,30.
Breast-related QoL
Five studies reported breast-specific QoL using Breast-Q18,24-27 (Table 2) and all of these had
a quality score of 19 or higher (moderate to high quality). The largest study (Hwang et al24)
had almost 1600 women in the CPM group. It compared Breast-Q results between women
who chose CPM and those who did not and reported results in reconstruction and noreconstruction groups. In women who did not choose reconstruction, there was no difference
in scores for any domain between CPM and no-CPM groups. Reconstruction was
associated with better QoL than no reconstruction regardless of choice for CPM. Scores in
the ‘satisfaction with breast’ domain were higher in the CPM group compared to the
unilateral mastectomy group, however the scores for psychosocial and physical well-being
domains were lower in the CPM group24. Two studies showed better satisfaction in the CPM
groups compared to unilateral mastectomy groups25,27 and the remaining two studies
showed better QoL scores in the no-CPM group18,26.
Overall quality of life
Three studies reported overall QoL21,22,32 (Table 3). One reported good QoL (8.7 out of 10) at
20 year follow-up on a single-item question in a CPM cohort without a comparison group21.
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Another found good QoL and no difference between CPM and no-CPM groups evaluated by
a single-item22. The third used FACT-B and found good QoL with no difference in CPM and
no-CPM groups 12 months after surgery32.
Satisfaction with the decision for CPM
Twelve studies evaluated at least one aspect of satisfaction or regret with the decision for
CPM7,14-16,20-23,28-31 (Table 3). The majority of these assessed satisfaction and regret with a
single-item closed question. Among 10 studies exploring satisfaction with CPM14-16,20-23,28-30,
82–98% of participants undergoing CPM expressed satisfaction. Satisfaction with the
decision for CPM was lower in women who had surgical complications20, a poor cosmetic
result, a diminished sense of sexuality or lack of information about surveillance versus
CPM28. Satisfaction was higher in women choosing simple mastectomy with no
reconstruction in one study20. Two studies compared satisfaction with the decision in women
undergoing CPM and women choosing against CPM15,23.One showed no difference between
the groups23 and the other showed higher satisfaction in the CPM group (97%) compared to
the no-CPM group (89%, no p-value reported). One study that used closed- and open-ended
questions found that satisfaction was 85% in a CPM cohort on the closed question but the
open-ended question showed responses that were positive in 30%, negative in 33% and
disparate in 35% of the sample14. Six studies asked a CPM cohort if they would make the
same decision again or recommend the procedure to other women; 83–97% responded that
they would do the same again or recommend it7,16,20,21,30,31. One study comparing a CPM to a
no-CPM group reported that 98% of the CPM group and 77% of the no-CPM group would
make the same decision again23.
Two studies used validated questionnaires to assess decisional regret. One study of 269
women undergoing CPM with 10 and 20 year follow-up used the Decision Conflict Scale and
found a mean score of 1.4 (scale 1–4), representing very low decisional conflict and stable
findings across both time periods21. The other used the SURE scale and found 87% of
women undergoing CPM scored 4/4 indicating no decisional conflict30.
Satisfaction with reconstruction and cosmesis
Four studies reported satisfaction with reconstruction and cosmesis15,16,30,31 (Table 3). In two
studies, satisfaction was high15,31. One reported 94% overall satisfaction31 and in another
there was no difference between bilateral (CPM) and unilateral mastectomy groups in
satisfaction with reconstruction (80% vs 79%, no p-value reported)15. However, another
interview study of 45 women reported that 89% of women choosing reconstruction after
CPM said the reconstruction did not live up to their expectations regarding sexuality,

6

reconstruction feeling like part of their body and risk of surgical complications. Despite this,
91% said they would make the same decision again16. Another study in women <40 years
reported that 45% felt the cosmetic result was as expected, 34% worse than expected and
25% better than expected; 90% would make the same decision again and SURE scores
showed low decisional conflict30. Breast reconstruction methods have improved over time,
however no change satisfaction levels were seen in studies across different study years.
Time since surgery also did not change satisfaction.
Fear of cancer recurrence
Five studies reported fear of cancer recurrence16,21,22,29,30 (online supplemental material
Appendix 3). All studies reported ongoing moderate to high levels of cancer or health worry
following CPM. One study used a validated questionnaire (Health Concern Score) and found
moderate levels of concern in a cohort of 269 women at 20 years21. The remaining studies
used questionnaires developed for the individual studies that included an item about fear of
recurrence. Current concern about cancer was reported by 49, 53, 82 and 90% of CPM
patients in these studies16,22,29,30. Only one of these studies compared the CPM to no-CPM
group and this reported concern about cancer to be higher in the non-CPM group (74%
reporting worry) compared to the CPM group (50%, p<0.05)22.
Body image and sexuality
Four studies reported body image15,21,22,30 (online supplemental material Appendix 3), four
reported sexuality16,19,22,30 and two studies reported these two outcomes together14,20. Three
studies used the validated Body Image Scale, either in full or in part, and two compared a
CPM group to a no-CPM group. These all showed that women reported concerns about their
body image, however there was no significant difference between CPM and no-CPM
groups15,22 with the exception of women who underwent CPM without reconstruction who
had slightly lower body image scores15. When asked if body image was as expected, 49%
said yes, 31% said it was worse than expected and 23% said it was better than expected30.
Similarly, in studies examining sexuality, there was no difference in score between the CPM
and no-CPM groups19,22. In an interview study, women reported feeling emotionally closer to
partners after the surgery compared to before the surgery, however sexually more distant,
with chest numbness related to CPM being a major factor (no comparison group)16.
One study that examined global psychological issues found that women reported CPM to
have a greater adverse effect on body image than other domains such as femininity,
sexuality, relationships and self-esteem20. Another study found that women had generally
positive comments about the impact of CPM on body image, sexuality and emotional
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domains; this was compared to generally negative comments from high-risk women without
cancer undergoing bilateral prophylactic mastectomy14.
Distress
Distress was reported in three studies21,22,32 (online supplemental material Appendix 3). Two
studies used the Impact of Events Scale and found that cancer related distress was
moderately high but there was no difference between CPM and no-CPM groups. The
remaining study used a general Health Distress Score and found low distress in the CPM
group (no comparison group) at 20 years21.
Other outcomes (5 studies).
Several other outcomes were reported (online supplemental material Appendix 3). These
included depression (two studies, prevalence of depression 27% in both, with no difference
between CPM and no-CPM groups22,29. There was also no difference between groups for
general health perception22. There were low levels of anxiety and high levels of optimism in
a CPM group (no comparison group)21 and pain and numbness were ‘about the expected
level’ in 40 and 51%30.
Discussion
This review includes patient-reported outcomes from 19 studies of 6,088 women with
unilateral cancer undergoing CPM (bilateral mastectomy). Significant heterogeneity was
noted among studies. Different methodology, outcomes and measurement tools were used
in different studies and outcomes were measured at varying time intervals. Study quality
also varied and fewer than half the studies had a quality score >20 (out of 24).
Most studies focused on how women felt about the decision to undergo CPM. Overall, these
showed that women were very comfortable with their decision. Satisfaction with the decision
was 82–98% across 10 studies, levels of decisional regret were low, and despite many
women being disappointed with their cosmetic outcome (up to 89% in one study), most
women reported they would make the same decision again and/or recommend CPM to other
women16. This evidence can provide clinicians with reassurance that women who are taking
control of their cancer and requesting CPM despite low risk of contralateral cancer are
unlikely to regret their decision.
The impact of surgery on body image was significant in women undergoing CPM. However,
in studies comparing the CPM group with a no-CPM group, there was no difference between
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groups15,22. This implies that it is the cancer surgery overall, not specifically the removal of
the contralateral breast, that is the cause. This is consistent with previous studies showing
that body image is dramatically and adversely affected by breast cancer surgery, even when
surgery is unilateral and the breast is conserved33. This is a strong and consistent finding
and was noted particularly in the higher-quality studies in this review such as those that used
Breast-Q.
A previous systematic review examining reasons for women choosing CPM found that fear
of cancer recurrence was the most important factor in the decision8. Other research has
shown that fear of recurrence was higher in women having breast conservation rather than
mastectomy on their ipsilateral side33. In this review, fear of cancer recurrence was still
prevalent among women who had undergone CPM. This shows that CPM probably does not
reduce fear of recurrence even though women may expect it to at the time they make the
decision. This has important implications for pre-operative counselling and informed
consent. It also demonstrates that psychological strategies, not surgery, should be used to
manage fear of cancer recurrence.
The previous review identified the desire for good cosmesis, symmetry and/or reconstructive
reasons as the second most important factor in the decision to undergo CPM8. The present
study did not find that satisfaction with the cosmetic outcome was any different for women
undergoing CPM compared to unilateral surgery15,31. However, only two studies examined
this issue. It is also possible that there is significant selection bias as women who are most
likely to experience asymmetry (such as those with larger breasts) may be more likely to
undergo CPM.
Clinical Implications
A patient requesting CPM from her surgeon may present an ethical dilemma. Patientcentred care is the aim, and the operation of CPM is associated with high levels of patient
satisfaction. It is, however, a major operation with significant potential complications
especially when performed with immediate breast reconstruction. The competing principles
of ‘autonomy’ and ‘non-maleficence’ are challenging for surgeons to balance, particularly at
a time of heightened distress typically associated with a cancer diagnosis.
However, dismissing a woman’s request to discuss CPM may be viewed as paternalistic and
limiting her right to fully informed decision-making. There is a significant body of literature
that reports benefits to CPM with bilateral reconstruction, as seen in this review. Unilateral
mastectomy may lead to post-surgical psychological distress due to asymmetry and poor
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body image. Weighing up the benefits and risks of unilateral versus bilateral surgery is
something that only the informed patient can do, based on her personal situation and values.
These ethical dilemmas underline the importance of providing each patient with as much
pre-operative information and support as she requires. Discussion about CPM, several
consultations and the input of a clinical psychologist may be required to fully inform the
patient about the risks of the surgery, the potential outcomes and importantly, the lack of
impact on fear of recurrence. Given that decisions regarding CPM usually need to be made
within a limited timeframe, decision-making aids may be beneficial. The role of decision aids
in this situation has recently been explored and shows promising results, especially in
facilitating a realistic (and usually reassuring) assessment of the true risk of contralateral
cancer as well as crucial (and often concerning) information about the additional surgical
risks34,35. Support is required as a woman makes this important and complex decision which
is likely to have long-term consequences for her QoL and psychological well-being.
Study Limitations
This review has several limitations. Significant heterogeneity of the studies was noted: a
large variety of different outcomes, time points, measures and comparison groups were
used in the studies, making conclusions difficult to draw. Study quality was highly variable,
and the majority of studies were retrospective. These limitations are true of many systematic
reviews. All of the studies were performed in the United States and Canada, so the
generalisability to other countries with different health systems and cultures (such as Europe
and Australia) is uncertain and there were no studies in non-English-speaking countries, so
no information is available about more culturally diverse populations. Future research in this
area would be facilitated by using more standardised methodology and validated
measurement tools and including a comparison group who did not undergo CPM. Moreover,
the role of combining evidence-based strategies to address fear of cancer recurrence with
pre-operative decision-making regarding CPM should be explored. A further area of potential
research could address the ethical issues around the provision of surgical procedures that
could be viewed as potentially hazardous and ‘medically unnecessary’ by surgeons but
‘valued’ by patients, using CPM as an example.
Conclusion
In conclusion, this review has built on previous research and added more depth to the
understanding of this area by presenting a detailed evaluation of studies of patient-reported
outcomes following CPM. Significant heterogeneity was found, presenting challenges for
synthesis of the data. Women undergoing surgery reported high levels of satisfaction with
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the decision, low levels of decisional regret and high satisfaction with cosmesis and
reconstruction. General and breast-specific QoL were high. Depression, distress and a
negative impact on body image were evident; however, levels were high in both CPM and
non-CPM groups. Fear of cancer recurrence was high after surgery. Women must be
informed about the potential benefits and harms of surgery, and the decision process must
include counselling about these factors in addition to the discussion about risk of future
cancer.
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Table 1: Characteristics of eligible studies (ordered by year of publication)
Author

Public
ation
year

Country

Study
years

Study
Design

Methodology

Partici
pants
(N
CPM)
296

Age
(years,
mean or
median)
53.8
(mean)
at CPM

Population

Outcomes reported

Outcome measures

Quality
score
(mean)

Montgomery28

1999

USA

19541998

R

Frost 200520

2005

USA

19601993

R

Mail
question
naire
and
interview
Mail
question
naire

CPM (bilateral mastectomy) with or
without reconstruction in patients with
unilateral BC. No comparison group.

Satisfaction with CPM decision,
Satisfaction with reconstruction.

Study-specific
questionnaire and
follow-up interview with
some participants.

18.5

583

48 at
CPM

CPM for unilateral BC, surveyed10 years
after BC. Family history of BC. Overlap
with population in Frost (2011).

Satisfaction with CPM, self-esteem,
feelings of femininity, sexual relationships,
level of stress, emotional stability,
complications.

Study-specific
questionnaire; closed
and open questions

17

Nekhlyudov29

2005

USA

19791999

R

Mail
question
naire

431

71%
<55yrs at
CPM

CPM (bilateral mastectomy) with or
without reconstruction in patients with
unilateral BC. No comparison group.

Study-specific
questionnaire plus
validated measuressingle item from SF-36
and full CES-D.

20

R

Mail
question
naire

519

30%
<55yrs at
survey

CPM (bilateral mastectomy) vs no CPM
(unilateral mastectomy or BCS) for
unilateral BC.

Past and current satisfaction with CPM
(single items), current fear of recurrence
(single item), current depression (CES-D),
current perception of general health
(single item from SF-36). Focused on role
in decision-making; also reported longterm outcomes.
Contentment with QoL, satisfaction with
CPM, experience of BC thoughts, body
image, sexual satisfaction, depression
and health perception.

Geiger22

2006

USA

19791990

19.5

19972003

P

Telepho
ne
interview

167

45 at
diagnosi
s

CPM (bilateral mastectomy) with or
without reconstruction in patients with
unilateral BC. No comparison group. All
had BRCA testing 15% positive.

QoL (FACT-B); psychological distress
(Impact of Events Scale; Multidimensional
Impact of Cancer Risk Assessment)

Study-specific
questionnaire and
adapted items from
validated scales; closed
questions
Validated scales: FACTB, IES, MICRA

Tercyak32

2007

USA

Spear31

2007

USA

20002005

R

Mail
question
naire

47

NR

CPM (bilateral mastectomy) with
immediate reconstruction in patients with
unilateral BC. Comparison bilateral riskreducing.

Satisfaction with reconstruction (rating
scale)

Study-specific
questionnaire.

14

21

12

Altschuler14

2008

USA

19791999

R

Mail
question
naire

567

18-80 at
survey

CPM vs bilateral prophylactic mastectomy.

QoL, satisfaction with CPM decision, BC
risk-related worry, body image, sexual
satisfaction and overall health perception

Study-specific mail
questionnaire; closed
and open questions.
Responses classified as
'positive,' 'negative' or
'disparate'
Standardised scales
with additional studyspecific items

20.5

Frost 201121

2011

USA

19601993

R

Mail
question
naire

269

47.4 at
CPM

CPM for unilateral BC, surveyed 10 years
and 20 years after cancer. Family history
of BC. Overlap with population in Frost
(2005).

Decision conflict scale, LOT-R optimism
scale, Trait anxiety, Health concern and
Health distress scales, QoL (single item),
body image scale (validated)

Han23

2011

USA

20052007

R

Mail
question
naire

101

Range
20-89

CPM vs no CPM (unilateral mastectomy)
for unilateral BC. Includes some bilateral
BC patients.

Satisfaction with choice of CPM and
choice of reconstruction

Study-specific
questionnaire.

15.5

Koslow25

2013

USA

R

Questio
nnaire

121

46.6 at
CPM

Rosenberg30

2013

USA +
Canada

20002007
(+2008
-2012)
NR

R

Mail
question
naire

123

37 at
diagnosi
s

CPM (bilateral reconstruction) vs no CPM
(unilateral reconstruction) in patients with
unilateral BC undergoing implant
reconstruction
CPM (bilateral mastectomy) with or
without reconstruction in patients with
unilateral BC. No comparison group.

Breast-related QoL (BREAST-Q, 5
domains)

BREAST-Q

21

BC worry (CPM survey), Decisional
conflict (SURE scale=items from
Decisional Conflict Scale). Focused on
knowledge and role in decision making;
also reported long term satisfaction.
Satisfaction with surgical procedure and
overall decision (Single-item questions)

Study-specific
questionnaire 'CPM
survey' 23 items, SURE
scale.

20.5

Soran7

2015

USA

20002010

R

Mail
question
naire

206

Study-specific
questionnaire.

18.5

Buchanan18

2016

USA

20112012

R

17

45.2 at
CPM

Hwang24

2016

USA

NR

R

Phone
interview
and mail
question
naire
E-mail
question
naire

CPM (bilateral reconstruction) vs no CPM
(unilateral reconstruction) in patients with
unilateral BC; comparing fear of
recurrence in different groups

Breast-related QoL (BREAST-Q, 5
domains), Fear of cancer recurrence
(Concerns About Recurrence Scale),
Interview

19

CPM (bilateral mastectomy) vs no CPM
(unilateral mastectomy) in patients with
unilateral BC; comparing reconstruction vs
no reconstruction

Breast-related QoL (BREAST-Q, 4
domains)

BREAST-Q, Concerns
About Recurrence
Scale, Semi-structured
interview exploring
decision-making
BREAST-Q

1598

53.7 at
survey

CPM (bilateral mastectomy) with or
without reconstruction in patients with
unilateral BC. No comparison group.

19

19.5

13

Anderson15

2017

USA

20042012

R

Mail
question
naire

262

55 at
diagnosi
s

CPM (bilateral mastectomy) vs no CPM
(unilateral mastectomy) with or without
reconstruction in patients with unilateral
BC; comparing satisfaction and body
image in different groups. Included BCS
patients.

Satisfaction with CPM decision (single
item), Satisfaction with reconstruction
(single item), body image (Body Image
Scale, adapted, 5 items)

Study-specific
questionnaires and
adapted validated body
image scale

20

Cornell19

2017

USA

20102015

R

Mail
question
naire

67

56 at
diagnosi
s

CPM (bilateral mastectomy) vs no CPM
(unilateral mastectomy) for unilateral BC.
Included BCS patients.

Sexual function, reported pre-op, and
post-op at regular intervals

19.5

Momoh27

2017

USA +
Canada

20122014

P

Inperson
question
naire

604

43% 4049 yrs

CPM (bilateral reconstruction) vs no CPM
(unilateral reconstruction) in patients with
unilateral BC; comparing implant vs
autologous reconstruction

Breast-related QoL (BREAST-Q, 4
domains), Health-related QoL (GAD),
Anxiety (PROMIS)

Female sexual
functioning index (FSFI)validated questionnaire
(19 items)
BREAST-Q, GAD-7,
PROMIS

Kuykendall26

2017

USA

20112015

R

Mail
question
naire

65

Not
reported

CPM (bilateral reconstruction) vs no CPM
(unilateral reconstruction) in patients with
unilateral BC; comparing implant vs
autologous reconstruction

Breast-related QoL (BREAST-Q, 10
domains)

BREAST-Q

21

Bloom16

2019

USA

NR

R

Inperson
interview

45

45 at
interview

CPM for unilateral, early-stage BC and low
genetic risk. Interview exploring decision
and effects.

Decision-making, short term and longterm impacts of CPM

Semi-structured
interview; open
questions

16.5

22

CPM: Contralateral prophylactic mastectomy; P: Prospective; R: Retrospective; NR: not reported; QoL: quality of life; BC=breast cancer
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Table 2: Results of studies assessing breast-related quality of life using Breast-Q, ordered by number of participants
Results for women undergoing CPM
Author

N (CPM
group)

Timing of
measurement

Groups assessed

Hwang24

1598

1.6 years
(median)
post-surgery

CPM with
reconstruction

Momoh27

604

Koslow25

121

Kuykendall

65

1 year postsurgery

52 months
(median)
post-surgery
nr

26

Buchanan18

17

22 months
(mean) postsurgery

BreastQ
satisfact
ion with
breast
62

Breast-Q
satisfaction with
outcome

Breast-Q
physical
well-being
abdomen

Breast-Q
psychosocial
well-being

Breast-Q
sexual wellbeing

Results/ Conclusions

71.7

Breast-Q
physical wellbeing
chest/upper
body
74.5

nr

nr

50

CPM (bilateral reconstruction) higher satisfaction with breast
compared with no CPM (unilateral reconstruction) at the
expense of lower psychosocial and physical well-being

CPM without
reconstruction

54

nr

nr

69.1

75

39.9

No differences in any domain scores in women not having
reconstruction

CPM with and
without
reconstruction

60.4

nr

nr

71.2

74.6

46.9

Reconstruction better QoL than no reconstruction regardless
of choice for CPM

CPM with implant
reconstruction
CPM with
autologous
reconstruction

50.25

nr

n/a

63.05

66.22

50.65

82.96

nr

79.98

65.57

67.76

52.41

CPM with bilateral reconstruction associated with better
satisfaction than no CPM with unilateral reconstruction
No differences in satisfaction between groups

CPM with implant
reconstruction

64.4

74.8

nr

75.4

77.4

55.1

CPM significantly better satisfaction with breast and
satisfaction with outcome.

CPM with implant
reconstruction

62.7

69.3

nr

71.6

69.5

51.6

No significant differences between CPM and no-CPM in group
with implant reconstruction.

CPM with
autologous (DIEP)
reconstruction
CPM with implant
or autologous
reconstruction

69

61

nr

71.2

66.5

49.5

No-CPM group better satisfaction with outcome and sexual
well-being in women undergoing DIEP

64.3

67.4

nr

71.5

68.7

51

Overall, no-CPM (unilateral reconstruction) significantly better
satisfaction with outcome, psychosocial well-being and sexual
well-being

Overall- CPM

82.2

89.9

nr

88†

74.4

71†

CPM associated with better satisfaction with breast and
outcome (non-significant); No CPM (unilateral reconstruction)
associated with better physical well-being (chest, significant)

†Result estimated from figure
N: number; CPM: Contralateral prophylactic mastectomy; NR: not reported
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Table 3: Results of studies assessing satisfaction with decision and satisfaction with reconstruction, ordered by number of participants
Author

n (CPM
group)

Timing of
measurement

Outcome and measurement tool

Groups assessed

Results/ Conclusions

Overall Quality of Life
Frost (2011)21
269

10 & 20 years

Multiple outcomes assessed at two follow-up times;
Validated questionnaires

CPM (bilateral mastectomy)

Overall QoL high; 10-point scale single item (Range 0-10, higher
score better qol). 20 year follow-up: 8.7 mean.

Geiger22

519

nr

Multiple outcomes assessed at follow-up. Study-specific
questionnaire.

CPM (bilateral mastectomy) vs No CPM
(unilateral mastectomy or BCS)

Contentment with QoL good (single item from FACT-B). CPM
group 76.3 satisfied 'quite a bit' or 'very much' No difference
between groups.

Tercyak32

167

1 and 12 months
after CPM

CPM (bilateral mastectomy) with or without
reconstruction in patients with unilateral BC. Comparison
group Non-CPM: unilateral mastectomy or BCS
(combined)

CPM (bilateral mastectomy). 81% had
reconstruction. Scores at 12 months.

FACT-B score (mean). CPM 115.9; Non-CPM 116.9 (Nonsignificant difference at 12 months)

Satisfaction with decision
Frost (2005)20
583

10 years

Multiple outcomes relating to decision and satisfaction
assessed at 10 years follow-up; study-specific
questionnaire

CPM (bilateral mastectomy)

Overall satisfaction with decision high. 83% satisfied or very
satisfied. Lower satisfaction in women with surgical complications
and subcutaneous mastectomy compared to simple mastectomy.
Higher satisfaction for no reconstruction vs reconstruction. Would
choose CPM again: 83%

Altschuler14

3-22 years

Satisfaction with CPM decision (Single item closed
question)

CPM (bilateral mastectomy)

Satisfaction with decision (closed question n=223): satisfied
85.2% not satisfied 14.8%. Better satisfaction expressed for CPM
compared to bilateral prophylactic mastectomy.

567

Satisfaction with decision (open question n=280): positive 30.1%,
negative 33.9%, disparate 35.8% Despite high satisfaction levels,
around 1/3 of women expressed disparate comments.
Geiger22

519

nr

Multiple outcomes assessed at follow-up. Study-specific
questionnaire.

CPM (bilateral mastectomy) vs No CPM
(unilateral mastectomy or BCS)

Satisfaction with CPM decision high (single item, developed for
study). CPM group 86.5% 'satisfied' or 'very satisfied.'

Nekhlyudov29

431

60% had CPM
within the past 10
years

Focused on decision-making roles (alone or shared with
doctor); also reported psychosocial outcomes.

CPM (bilateral mastectomy)

Focused on decision-making roles (alone or shared with
doctor); also reported psychosocial outcomes.

CPM (bilateral mastectomy)

Satisfaction with choice for CPM (6 months). 352/431 (81.7%)
satisfied. Active decision-making roles more likely to be satisfied
at 6 months.
Satisfaction with choice for CPM (current). 367/431 (85.2%)
satisfied. Decision-making roles not related to current satisfaction.
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Montgomery28

Frost (2011)21

296

269

Median 4.9 years;
53% > 10 years

10 & 20 years

Assessed satisfaction with decision (regret) with studyspecific questionnaire. Follow-up phone interview with
women who expressed regret to assess reasons.

CPM (bilateral mastectomy)

Satisfaction with choice for CPM. Low level of regret. 278/296
(94%) satisfied. Reasons for regret: poor cosmetic result (CPM or
recon), diminished sense of sexuality, lack of education regarding
alternative surveillance methods or CPM efficacy.

Assessed satisfaction with decision (regret) with studyspecific questionnaire. Follow-up phone interview with
women who expressed regret to assess reasons.

CPM (bilateral mastectomy)

Multiple outcomes assessed at two follow-up times;
Collection of validated questionnaires

CPM (bilateral mastectomy)

Satisfaction with choice for reconstruction. 37.5% had
reconstruction; 12/111 (10.8%) with CPM and reconstruction had
regrets. 6/185 (3.2%) with CPM and no reconstruction had
regrets. CPM and no recon (3.2%) had lower regret than CPM
with recon (10.8%).
Decision-conflict scale (Range 1-5, high score= greater conflict)
20 year follow-up: 1.4 mean; 95% satisfied with their decision.
Very low decisional conflict score. Stable findings between 10 and
20 year surveys.

Anderson15

262

3.6 years (mean)

Satisfaction with CPM decision (single item)

CPM (bilateral mastectomy) vs No CPM
(unilateral mastectomy)

Soran7

207

93% >1 year

Focused on decision-making role and reasons; also
reported satisfaction with decision.

CPM (bilateral mastectomy)

Focused on decision-making role and reasons; also
reported satisfaction with decision.

CPM (bilateral mastectomy)

Focused on decision-making role and reasons; also
reported psychosocial outcomes.

CPM (bilateral mastectomy) with or without
recon

Overall satisfaction with decision high: 20 year follow-up: 90%
satisfied or very satisfied.
Would choose CPM again: 20 year follow-up: 92% would choose
CPM again. Stable between 10 and 20 year surveys.
Satisfaction with decision for CPM: CPM group 97% satisfied
with decision; No-CPM group 89% satisfied with decision.
Satisfaction slightly higher in CPM compared to no-CMP group (pvalue nr)
Would recommend to other women (single item). 191/200 (92.7%)
would recommend to others. High level of satisfaction.
Satisfaction with surgical procedure of CPM (single item). 200/206
(91.7%) satisfied. High satisfaction levels.
(Single item). 199/206 (96.6%) would choose CPM again.

Rosenberg30

123

2.1 years mean

Decisional conflict about choice for CPM low (SURE scale). 87%
of respondents scored 4/4, indicating no decisional conflict
Satisfaction with choice for CPM high. 80% of women were
extremely confident in their decision to undergo CPM and 90% of
respondents would definitely choose CPM if deciding again.

Han23

101

nr

Assessed satisfaction with decision for CPM and for
reconstruction. Study-specific mailed questionnaire.

CPM (bilateral mastectomy) vs No CPM
(unilateral mastectomy)

Satisfaction with choice for reconstruction high. 125/242 52%
(CPM and no-CPM combined) had reconstruction; 89% of
patients satisfied with their decision for or against reconstruction;
no difference between CPM/no-CPM groups.
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Satisfaction with choice for CPM high. CPM group 99/101 (98%),
No-CPM group 90/117 76.9% would make the same decision
again. CPM significantly more likely to make same decision again
Spear31

47

Mean 31 months

CPM (bilateral mastectomy) with immediate
reconstruction in patients with unilateral BC. Comparison
bilateral risk-reducing.

CPM (bilateral mastectomy)

High satisfaction; 31/32 (98%) would choose again.

Bloom16

45

1-10 years

Decisional regret (Semi-structured interview; open
questions)

CPM (bilateral mastectomy)

Satisfaction with decision 41/45 (91%) would make the same
decision again.

Satisfaction with reconstruction (single item)

CPM (bilateral mastectomy with
reconstruction) vs No CPM (unilateral
mastectomy with reconstruction)

Satisfaction with breast reconstruction high: CPM group 80%
satisfied; No-CPM group 79% satisfied. Young women, all <40
yrs. >90% reconstruction rate.

CPM (bilateral mastectomy) with or without
reconstruction
CPM (bilateral mastectomy)

CPM (bilateral mastectomy)

Cosmetic result. Worse than expected 34%; about what expected
45%; better than expected 25%
Satisfaction with reconstruction. Overall 30/32 (94%) satisfied.
Highly satisfied 30/32 (53%); Very satisfied 8/32 (25%); Mod
satisfied 4/32 (13%); Satisfied 1/32 (3%); Disappointed 2/32 (6%);
Very disappointed 0/32 (0%)
Satisfaction with reconstruction. 38/45 had reconstruction; 89%
said reconstruction did not live up to expectations; reported that
their expectations were unrealistic for sexuality, feeling like part of
their body and potential surgical complications

Satisfaction with reconstruction and cosmesis
Anderson15
262
3.6 years (mean)

Rosenberg30

123

2.1 years (mean)

Spear31

47

31 months (mean)

Focused on decision-making role and reasons; also
reported psychosocial outcomes.
CPM (bilateral mastectomy) with immediate
reconstruction in patients with unilateral BC. Comparison
bilateral risk-reducing.

Bloom16

45

1-10 years

Semi-structured interview; open questions

N=number; CPM: Contralateral prophylactic mastectomy; NR: not reported; QoL= quality of life; BC=breast cancer
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Appendix 1: Study inclusion and exclusion criteria
Inclusion criteria
•

•
•

•

•
•

Studies of women with breast
malignancy (DCIS or invasive cancer)
AND
Studies of women who have
previously undergone CPM AND
Original research articles from peerreviewed journals AND
Studies reporting patient-reported
outcomes following CPM such as,
quality of life, cosmetic outcome,
decisional regret AND
Quantitative or qualitative study
design AND
Retrospective or prospective study
design

Exclusion criteria
•
•
•

•
•
•

•
•

Studies of women without a breast
cancer diagnosis
Studies not including patient reported
outcomes
Studies of women at high-risk of breast
cancer such as BRCA1/2 mutation
carriers
Studies of women planning future CPM
Studies of women with bilateral breast
cancer
Studies of women with a past history of
breast cancer and new contralateral
breast cancer
Review papers, Editorials, Case reports
and Abstract-only presentations
Papers published in languages other than
English

CPM=contralateral prophylactic mastectomy

24

Appendix 2: Search terms for MEDLINE, PubMed and PsycINFO
English language, human studies
Double mastectomy OR bilateral mastectomy OR contralateral prophylactic mastectomy
OR prophylactic mastectomy OR preventive mastectomy
AND
Breast neoplasms OR early stage breast cancer
AND
Patient reported outcomes OR patient reported outcome measures OR patient outcome
assessment OR self report OR patient satisfaction OR patient acceptance OR quality of life
OR well-being OR stress, psychological OR morbidity OR regret OR postoperative
complications OR adverse effects OR cosmetic outcome OR anxiety OR depression OR
self-esteem OR self-concept OR body image OR body appearance OR femininity OR
sexuality OR sexual relationships OR relationship
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Appendix 3: Results of studies assessing various patient-reported outcomes, ordered by number of participants

Study

n (CPM
group)

Fear of cancer recurrence
Geiger1
519

Timing of
measurement

Outcome and measurement tool

Groups assessed

Results/ Conclusions

nr

Multiple outcomes assessed at follow-up. Study
specific questionnaire.

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)

Concern about BC (single item, developed for study). CPM
group 50.3% 'concerned' or 'very concerned.' No-CPM
group 73.8%; p=0.004. CPM group significantly less
concern about BC
Fear of recurrence (current). 210/431 (48.7%)

Nekhlyudov2

431

60% had CPM
within the past 10
years

Focused on decision making roles (alone or shared
with doctor); also reported psychosocial outcomes.

CPM (bilat mastectomy)

Frost (2011)3

269

10 & 20 years

CPM (bilat mastectomy)

Rosenberg4

123

2.1 years mean

Multiple outcomes assessed at two follow-up times;
Collection of validated questionnaires
Focused on decision making role and reasons; also
reported psychosocial outcomes.
Focused on decision making role and reasons; also
reported psychosocial outcomes.
Semi-structured interview; open questions

CPM (bilat mastectomy) with or without recon

Multiple outcomes assessed at follow-up. Study
specific questionnaire.

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)

Multiple outcomes assessed at follow-up. Study
specific questionnaire.

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)

Multiple outcomes assessed at two follow-up times;
Collection of validated questionnaires

CPM (bilat mastectomy)

Bloom5

45

1-10 years

Body image
Geiger1

519

nr

Frost (2011)3

269

10 & 20 years

CPM (bilat mastectomy) with or without recon

CPM (bilat mastectomy)

Health concern score moderate (Range 1-100, higher score
greater concern) 20 year follow-up: 55.8 mean
Fear of recurrence high (current). 87% said they had been
very worried about contralateral cancer at the time of CPM;
90% reported 'at least a little' worry about cancer at followup.
Worry/anxiety about cancer. Worse than expected 23%;
about what expected 51%; better than expected 24%
Fear of recurrence/ 'peace of mind': 82% did not report
peace of mind; continued to worry about metastatic
disease.
Self-conscious about appearance (single item from Body
Image Scale). CPM group 21.1% self-conscious. No
difference between groups; included BCS patients.
Satisfied with appearance when dressed (single item from
Body Image Scale). CPM group satisfied 59.3%. No
difference between groups; included BCS patients)
Body image scale (Range 0-30, high score more distress).
20 year follow-up: 5.0 mean total score; Items: feeling less
attractive 11%, less feminine 8%, self-conscious 10%, less
whole 8%, dissatisfied with appearance 7%. Significant
impact of surgery on body image.
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Anderson6

262

3.6 years (mean)

Body Image Scale, adapted (5 items)

CPM (bilat mastectomy) vs no CPM (unilat
mastectomy) with or without recon

Rosenberg4

123

2.1 years mean

Focused on decision making role and reasons; also
reported psychosocial outcomes.

CPM (bilat mastectomy) with or without recon

Sexuality
Geiger1

519

nr

Rosenberg4

123

2.1 years mean

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)
CPM (bilat mastectomy) with or without recon

Cornell7

67

12 months

Multiple outcomes assessed at follow-up. Study
specific questionnaire.
Focused on decision making role and reasons; also
reported psychosocial outcomes.
Female sexual functioning index (FSFI)- validated
questionnaire (19 items); 36 max score; 26 indicates
sexual dysfunction

Bloom5

45

1-10 years

Semi-structured interview; open questions

CPM (bilat mastectomy)

CPM (bilat mastectomy) vs no CPM (unilat
mastectomy) for unilateral BC. Also included BCS
cohort.

Body image, sexuality and emotional domains (combined)
Frost (2005)8
583
10 years
Multiple outcomes relating to decision and
satisfaction assessed at 10 years follow-up; studyspecific questionnaire

CPM (bilat mastectomy)

Altschuler9

Study-specific mail questionnaire; closed and open
questions

CPM (bilat mastectomy)

Study-specific mail questionnaire; closed and open
questions

Bilateral prophylactic mastectomy

567

3-22 years

Body image scale. CPM (bilat) without recon 14.4; CPM
(bilat) with recon 16.4; No CPM (unilat) without recon 16.7;
No CPM (unilat) with recon 16.1. Worse body image in
CMP no-recon group compared to other 3 groups.
Self-conscious about appearance. Worse than expected
31%; about what expected 49%; better than expected 23%
Satisfied with sex life (single item from FACT-B). CPM
group satisfied 40.9%. No difference between groups.
Sense of sexuality. Worse than expected 42%; about what
expected 39%; better than expected 14%
FSFI score (baseline and follow-up, p-value) CPM 23.7,
22.8, p=0.74; No CPM 25.2, 17.4, p=0.010; BCS 26.3, 23.5,
p<0.001. No difference between three groups in baseline
overall scores. All scores reduced at follow-up. Change at
follow-up was significant in BCS and unilat mastectomy
group but not in CPM group. However, sexual function in
CPM group was still low.
Sexual intimacy. Majority reported feeling emotionally closer
but sexually more distant from partner. Sexual dysfunction/
lack of interest in sex reported. Numbness on chest a major
factor.
Psychological impacts. Reporting an adverse effect on:
femininity 26%, sexual relationships 23%, stress in life 17%,
emotional stability 12%, self-esteem 17%, body appearance
33%. Adverse effect on body appearance (33%) is higher
than other adverse effects.
General feelings in body image, sexuality and emotional
domains (open question n=75): positive 50.7%, negative
32%, disparate 17.3%. Better outcomes in body image,
sexuality and emotional domains for CPM compared to
bilateral prophylactic mastectomy.
General feelings in body image, sexuality and emotional
domains (open question n=143): positive 26.6%, negative
47.6%, disparate 25.9%. More negative than positive
comments in body image, sexuality and emotional domains

Distress

27

Geiger1

519

nr

Multiple outcomes assessed at follow-up. Study
specific questionnaire.

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)

Avoiding thoughts about BC moderately high (single item
from Impact of Events Scale). CPM group 58.6% 'modest'
or 'high' avoidance. No difference between groups.

Multiple outcomes assessed at follow-up. Study
specific questionnaire.

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)

Multiple outcomes assessed at two follow-up times;
Collection of validated questionnaires
CPM (bilat mastectomy) with or without
reconstruction in patients with unilateral BC.
Comparison group Non-CPM: unilat mastectomy or
BCS (combined)

CPM (bilat mastectomy)

Experiencing intrusive BC thoughts moderately high (single
item from Impact of Events Scale). CPM group 64.9%
'modest' or 'high' intrusiveness. No difference between
groups.
Health distress score low (Range 1-100, higher score
greater concern). 20 year follow-up: 14.1 mean
Cancer-specific distress: Impact of Events Scale (IES).
CPM 14.2; Non-CPM 14.6 (Non-significant difference)

Frost (2011)3

269

10 & 20 years

Tercyak10

167

1 and 12 months
after CPM

Geiger1

519

nr

Multiple outcomes assessed at follow-up. Study
specific questionnaire.
Multiple outcomes assessed at follow-up. Study
specific questionnaire.

CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)
CPM (bilat mastectomy) vs No CPM (unilat
mastectomy or BCS)

Nekhlyudov2

431

60% had CPM
within 10 years

Focused on decision making roles (alone or shared
with doctor); also reported psychosocial outcomes.

CPM (bilat mastectomy)

Frost (2011)3

269

10 & 20 years

Multiple outcomes assessed at two follow-up times;
Collection of validated questionnaires
Multiple outcomes assessed at two follow-up times;
Collection of validated questionnaires
Focused on decision making role and reasons; also
reported psychosocial outcomes.
Focused on decision making role and reasons; also
reported psychosocial outcomes.

CPM (bilat mastectomy)

CPM (bilat mastectomy). 81% had reconstruction.
Scores at 12 months.

Other

Rosenberg4

123

2.1 years mean

CPM (bilat mastectomy)
CPM (bilat mastectomy) with or without recon
CPM (bilat mastectomy) with or without recon

Possible Depression (CES-D>=16). CPM group 27%
depression. No difference between groups.
General health perception (single item from Medical
Outcomes Study Short Form-36). CPM group 46.7% 'very
good' or 'excellent.' No difference between groups.
Depressive symptoms (current) CES-D >=16. 114/431
(26.5%). Depressive symptoms more likely in women who
shared decision making.
LOT-R optimism scale (Range 1-24, high score greater
optimism). 20 year follow-up: 18.5 mean- high scores
Trait anxiety low (Range 20-80, higher score greater
anxiety). 20 year follow-up: 32.1 mean
Pain at surgical site. Worse than expected 25%; about what
expected 40%; better than expected 30%
Numbness/tingling in chest. Worse than expected 28%;
about what expected 51%; better than expected 15%

N=number; CPM: Contralateral prophylactic mastectomy; NR: not reported; BC=breast cancer
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